Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00354328 · ClinicalTrials.gov registry record

Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy

A clinical trial of Myocardial Infarction and Ischemic Heart Disease, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Completed
Registry status
110
Enrollment target
1
Study location

NCT00354328 is a study of Myocardial Infarction and Ischemic Heart Disease that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 110 participants, below the 4,680-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00354328, a study of Myocardial Infarction and Ischemic Heart Disease, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

COMPLETED
Registry status
110 participants
Enrollment target
1
Study location

Study Summary

This study will examine the relationship between certain measures of heart function and exercise capacity in patients with hypertrophic cardiomyopathy (HCM). Patients who participated in NHLBI studies 01-H-0006 ("Double Blind Placebo-Controlled Study of Pirfenidone - A Novel Anti-Fibrotic Drug - in Symptomatic Patients with Hypertrophic Cardiomyopathy Associated with Left Ventricular Diastolic Dysfunction") and 96-H-0144 ("Double Blind Placebo-Controlled Study of Long-Term Effects of Angiotensin-Converting Enzyme Inhibition (Enalapril) and Angiotensin II Receptor Blockade (Losartan) on Genetically-Induced Left Ventricular Diastolic Dysfunction") are eligible for this study. Data from echocardiograms and measures of left ventricular pressure obtained from patients in those studies will be analyzed in the current study to assess their influence on exercise capacity. No additional tests, treatments or other procedures are required. Information from this study may help in the development of improved drug treatments for HCM.

Conditions Studied

Myocardial Infarction Ischemic Heart Disease Angina, Unstable

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2005-05-27
Est. Completion 2013-10-22

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

501 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00354328

The ClinicalTrials.gov registry entry for NCT00354328 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,680-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (98% lower). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.

NCT00354328 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00354328 about?

NCT00354328 is a clinical study titled "Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy". This study will examine the relationship between certain measures of heart function and exercise capacity in patients with hypertrophic cardiomyopathy (HCM). Patients who participated in NHLBI studies 01-H-0006 ("Double Blind Placebo-Controlled Study of Pirfenidone - A Novel Anti-Fibrotic Drug - in...

What is the current status of trial NCT00354328?

This trial is currently completed. The enrollment target is 110 participants. The study started on 2005-05-27. Estimated completion is 2013-10-22.

What conditions does trial NCT00354328 study?

This clinical trial studies the following conditions: Myocardial Infarction, Ischemic Heart Disease, Angina, Unstable.

Who is sponsoring clinical trial NCT00354328?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00354328 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myocardial Infarction

All registered trials for this condition

Ischemic Heart Disease

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.